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Abstract: The emerging carbon nanomaterial graphene (G) and its oxidized derivative
graphene oxide (GO) have recently gained considerable attention in biomedical
applications such as cancer therapy or biosensors. It has for example been
demonstrated that G has an efficient bioconjugation with common
biomolecules and activates cell differentiation of neuronal stem cells (Li et al.,
2013). This way, G could acts as a physical support or scaffold to promote
differentiation and axonal sprouting of dopaminergic (DA) cells derived from
neural stem cells. Since GO in its multilayer form and with multiple carboxylate
and epoxy groups seems to show interesting biological properties (Yang et al.,
2013) the aim of the present work has been to test different graphene
derivatives searching for the best scaffold to be used in stem cell
differentiation. For this purpose we have tested the cytotoxicity of GO and
reduced GO, and specifically its biocompatibility with SN4741, a dopaminergic
cell line derived from mouse substance nigra, measuring the effect on long term
culture. The cells were cultured in Dulbecco’s modified Eagle’s medium 10%
FCS (Gibco) to about 80% confluence. Cells (1.000) were plated onto 96-well
microliter plates with graphene using three chemically different types of GO as
powders and films: 1) hydrophilic GO; 2) partially reduced GO (PRGO) which
is hydrophobic and 3) fully reduced GO (FRGO), also hydrophobic, each of
them in five concentrations: 1 mg/ml; 0.1 mg/ml; 0.05 mg/ml; 0.02 mg/ml and
0.01 mg/ml. Cells were cultured with GO and cell viability was determined
after 24 hours, 1 week and 2 weeks using the MTT assay (Roche) and
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cytotoxicity was determined by the lactate dehydrogenase (LDH) assay
(Roche). Our results show positive biocompatibility between the G-derivatives
and SN4741 cells. We conclude that the use of our G-derivative scaffolds can
enhance the morphological differentiation towards DA neurons (TH positive)
providing microenvironments appropriate for neural differentiation and axon
guidance. These findings suggest that biocompatible scaffolds can contribute to
the future generation of successful clinical applications of G. Future
experiments will examine whether G could offer a platform for neural stem cell
and neural regeneration for neurological diseases such as PD. (Refs: Li N.,
Zhang Q, Gao S. et al., 2013, Nature/Sci Rep. 3:1604. doi: 10.1038/srep01604;
Yan K., Li Y., Tan X., et al., 2013, Small., 9(9-10): 1492-1503) This work has
been supported by the University of Malaga, Campus de Excelencia
Internacional Andalucía Tech, Spain; The Norwegian Research Council (grant
nº 215086) and funds from Karolinska Institutet, Stockholm, Sweden.
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